Relay Drug Delivery for Amplifying Targeting Signal and Enhancing Anticancer Efficacy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28160337.
- Also identified by DOI 10.1002/adma.201605803.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A "relay drug delivery" system based on two distinct modules, which is composed of a signal transmission nanocarrier A (NC<sub>A</sub> ) that can specifically induce tumor blood vessel inflammation generation and an execution biomimetic nanocarrier B (NC<sub>B</sub> ) that can accumulate at the tumor site by receiving the broadcasting signals generated by NC<sub>A</sub> , is developed for amplifying active tumor targeting signal and enhancing antitumor therapy.
Medical subject headings
- Antineoplastic Agents
- Biomimetic Materials
- Drug Delivery Systems
- Nanostructures
- Neoplasms